Related Experiment Videos
Inhibition of the growth of human coronavirus 229E by leupeptin
Abstract:
The protease inhibitor leupeptin prevented multiplication of the human coronavirus strain 229E in cultures of MRC-C cells. The IC50 of leupeptin in plaque reduction tests was 0.4 micrograms/ml, whereas growth of host cells was unaffected by leupeptin at 50 micrograms/ml. Inhibition of plaque formation could be prevented by the addition of proteases to the overlay medium. In single-cycle growth experiments, leupeptin reduced virus yield only if added within 2 h of infection, indicating its action on an early stage of virus replication.
Insights
The protease inhibitor leupeptin blocks human coronavirus 229E replication in cell cultures. This antiviral effect occurs early in the virus life cycle, offering potential therapeutic strategies against coronavirus infections.
Area of Science:
- Virology
- Cell Biology
- Pharmacology
Background:
- Human coronavirus 229E (HCoV-229E) is an important respiratory pathogen.
- Proteases play a role in the replication cycle of various viruses.
- Antiviral strategies targeting viral proteases are actively investigated.
Purpose of the Study:
- To investigate the effect of the protease inhibitor leupeptin on HCoV-229E replication.
- To determine the stage of viral replication affected by leupeptin.
- To assess the therapeutic potential of leupeptin against HCoV-229E.
Main Methods:
- Plaque reduction assays were performed using MRC-C cells and HCoV-229E.
- The IC50 of leupeptin was determined.
- Single-cycle growth experiments were conducted with varying leupeptin addition times.
- The effect of exogenous proteases on leupeptin's antiviral activity was assessed.
Main Results:
- Leupeptin significantly inhibited HCoV-229E multiplication with an IC50 of 0.4 µg/ml.
- Host cell growth remained unaffected by leupeptin up to 50 µg/ml.
- Leupeptin's inhibitory effect was reversed by the addition of proteases.
- Antiviral activity was observed only when leupeptin was added within 2 hours post-infection.
Conclusions:
- Leupeptin effectively inhibits HCoV-229E replication by targeting an early stage of the viral life cycle.
- The findings suggest that viral proteases are essential for early HCoV-229E replication.
- Leupeptin demonstrates potential as an antiviral agent against HCoV-229E infections.